These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29674133)

  • 1. Analysis of the DNA methylation profiles of miR-9-3, miR-34a, and miR-137 promoters in patients with diabetic retinopathy and nephropathy.
    Dos Santos Nunes MK; Silva AS; Wanderley de Queiroga Evangelista I; Modesto Filho J; Alves Pegado Gomes CN; Ferreira do Nascimento RA; Pordeus Luna RC; de Carvalho Costa MJ; Paulo de Oliveira NF; Camati Persuhn D
    J Diabetes Complications; 2018 Jun; 32(6):593-601. PubMed ID: 29674133
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic Mechanisms in Type 2 Diabetes Retinopathy: A Systematic Review.
    Milluzzo A; Maugeri A; Barchitta M; Sciacca L; Agodi A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of genetic variants for diabetic retinopathy in Taiwanese patients with diabetic nephropathy.
    Hsieh AR; Huang YC; Yang YF; Lin HJ; Lin JM; Chang YW; Wu CM; Liao WL; Tsai FJ
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of let-7a-3 is relevant to its down-expression in diabetic nephropathy by targeting UHRF1.
    Peng R; Liu H; Peng H; Zhou J; Zha H; Chen X; Zhang L; Sun Y; Yin P; Wen L; Wu T; Zhang Z
    Gene; 2015 Oct; 570(1):57-63. PubMed ID: 26049093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into DNA methylation and its critical implications in diabetic vascular complications.
    Zheng J; Cheng J; Zhang Q; Xiao X
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28183874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between the MTHFR gene polymorphism and diabetic retinopathy in type 2 diabetic patients without overt nephropathy.
    Yoshioka K; Yoshida T; Takakura Y; Kogure A; Umekawa T; Toda H; Yoshikawa T
    Diabetes Care; 2003 Jun; 26(6):1947-8; author reply 1948. PubMed ID: 12766148
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes.
    Ray D; Mishra M; Ralph S; Read I; Davies R; Brenchley P
    Diabetes; 2004 Mar; 53(3):861-4. PubMed ID: 14988276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
    Kang WL; Xu GS
    Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 21 Emerging Role in Diabetic Complications: A Critical Update.
    Roy D; Modi A; Khokhar M; Sankanagoudar S; Yadav D; Sharma S; Purohit P; Sharma P
    Curr Diabetes Rev; 2021; 17(2):122-135. PubMed ID: 32359340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy.
    Fujita H; Narita T; Meguro H; Ishii T; Hanyu O; Suzuki K; Kamoi K; Ito S
    Horm Metab Res; 2000 Feb; 32(2):80-3. PubMed ID: 10741691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients.
    Coskun ZM; Ersoz M; Adas M; Hancer VS; Boysan SN; Gonen MS; Acar A
    Arch Med Res; 2019 Apr; 50(3):91-97. PubMed ID: 31495395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms.
    Kaur P; Kotru S; Singh S; Munshi A
    J Physiol Biochem; 2022 Feb; 78(1):19-37. PubMed ID: 35098434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes.
    Neugebauer S; Baba T; Watanabe T
    Diabetes; 2000 Mar; 49(3):500-3. PubMed ID: 10868974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes: response to Wang et al.
    P K Ng D; Chia KS; Koh D
    Diabetes Care; 2004 Jan; 27(1):289-90; author reply 290. PubMed ID: 14694018
    [No Abstract]   [Full Text] [Related]  

  • 16. Mapping the methylation status of the miR-145 promoter in saphenous vein smooth muscle cells from individuals with type 2 diabetes.
    Riches K; Huntriss J; Keeble C; Wood IC; O'Regan DJ; Turner NA; Porter KE
    Diab Vasc Dis Res; 2017 Mar; 14(2):122-129. PubMed ID: 28185533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the angiotensin I-converting enzyme gene in diabetic nephropathy in type II diabetic patients with proliferative retinopathy.
    Hanyu O; Hanawa H; Nakagawa O; Tani N; Andou N; Aizawa Y; Shibata A
    Ren Fail; 1998 Jan; 20(1):125-33. PubMed ID: 9509566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between the heparan sulfate proteoglycan gene polymorphism and diabetic nephropathy in Japanese NIDDM with proliferative diabetic retinopathy.
    Fujita H; Narita T; Meguro H; Ishii T; Hanyu O; Suzuki K; Ito S
    Ren Fail; 1999 Nov; 21(6):659-64. PubMed ID: 10586428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential DNA methylation of microRNAs within promoters, intergenic and intragenic regions of type 2 diabetic, pre-diabetic and non-diabetic individuals.
    Pheiffer C; Erasmus RT; Kengne AP; Matsha TE
    Clin Biochem; 2016 Apr; 49(6):433-438. PubMed ID: 26656639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of CTGF gene promoter methylation with CTGF expression in type 2 diabetes mellitus with or without nephropathy.
    Zhang H; Cai X; Yi B; Huang J; Wang J; Sun J
    Mol Med Rep; 2014 Jun; 9(6):2138-44. PubMed ID: 24676352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.